Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| COMMONWEALTH BIOTECHNOLOGIES INC | 80,411 | reported | 01 Apr 2025 | tx 2+100,000 |
| MIRA PHARMACEUTICALS, INC. | 25,000 | reported | 25 Mar 2024 | tx 1+50,000 |
| Telomir Pharmaceuticals, Inc. | 25,000 | reported | 27 Aug 2024 | tx 1+25,000 |
| Alaunos Therapeutics, Inc. | 9,589 | reported | 12 Jan 2026 | tx 4+22,789 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jan 2026 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 5,406 | 2.89 USD | |
| 21 Nov 2025 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 4,183 | 3.16 USD | |
| 15 Jul 2025 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 3,200 | 0.00 USD | deriv |
| 15 Jul 2025 | GRANT_AWARD | Alaunos Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 50,000 | 0.00 USD | |
| 27 Aug 2024 | GRANT_AWARD | Telomir Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 50,000 | 0.00 USD | |
| 25 Mar 2024 | GRANT_AWARD | MIRA PHARMACEUTICALS, INC. | 50,000 | 0.00 USD | deriv |